Astria Therapeutics (ATXS) Institutional Ownership $5.79 +0.08 (+1.40%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$5.79 0.00 (0.00%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Astria Therapeutics (NASDAQ:ATXS)CurrentInstitutional OwnershipPercentage98.98%Number ofInstitutional Buyers(last 12 months)60TotalInstitutional Inflows(last 12 months)$93.37MNumber ofInstitutional Sellers(last 12 months)28TotalInstitutional Outflows(last 12 months)$57.11M Get ATXS Insider Trade Alerts Want to know when executives and insiders are buying or selling Astria Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ATXS Institutional Buying and Selling by Quarter Astria Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2025 Jane Street Group LLC108,898$582K0.0%+317.3%0.193% 5/16/2025 Goldman Sachs Group Inc.158,588$847K0.0%-26.8%0.281% 5/16/2025 Millennium Management LLC1,634,155$8.73M0.0%-18.1%2.896% 5/16/2025 Adage Capital Partners GP L.L.C.588,200$3.14M0.0%-17.5%1.042% 5/16/2025 ADAR1 Capital Management LLC641,690$3.43M0.6%+605.3%1.137% 5/15/2025 Redmile Group LLC269,078$1.44M0.1%-22.3%0.477% 5/15/2025 PDT Partners LLC28,707$153K0.0%+173.2%0.051% 5/15/2025 Nantahala Capital Management LLC669,530$3.58M0.1%-0.8%1.186% 5/15/2025 Cubist Systematic Strategies LLC92,239$493K0.0%+503.7%0.163% 5/15/2025 DAFNA Capital Management LLC314,775$1.68M0.5%+5.0%0.558% Get the Latest News and Ratings for ATXS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Astria Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/15/2025 Driehaus Capital Management LLC1,428,217$7.63M0.1%-8.6%2.531% 5/14/2025 MetLife Investment Management LLC23,349$125K0.0%-13.5%0.041% 5/14/2025 Walleye Capital LLC100,107$535K0.0%-31.2%0.177% 5/14/2025 Jump Financial LLC33,305$178K0.0%N/A0.059% 5/14/2025 AlphaQuest LLC14,216$76K0.0%+100.9%0.025% 5/14/2025 Hsbc Holdings PLC32,808$174K0.0%+70.3%0.058% 5/14/2025 Wellington Management Group LLP152,611$815K0.0%+3.1%0.270% 5/13/2025 Brooklyn Investment Group8,694$46K0.0%+1,079.6%0.015% 5/13/2025 American Century Companies Inc.52,107$278K0.0%+22.1%0.092% 5/13/2025 Fox Run Management L.L.C.34,320$183K0.0%N/A0.061% 5/12/2025 Nuveen LLC103,517$553K0.0%N/A0.183% 5/12/2025 Swiss National Bank49,200$263K0.0%-26.1%0.087% 5/9/2025 Deutsche Bank AG35,333$189K0.0%-11.1%0.063% 5/9/2025 Charles Schwab Investment Management Inc.315,016$1.68M0.0%-2.3%0.558% 5/7/2025 Corton Capital Inc.13,534$72K0.2%N/A0.024% 4/30/2025 Alps Advisors Inc.43,444$232K0.0%-4.8%0.077% 4/7/2025 GAMMA Investing LLC8,678$46K0.0%+1,127.4%0.015% 3/18/2025 California State Teachers Retirement System32,561$291K0.0%+9.9%0.058% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC63,452$567K0.0%+13.9%0.112% 2/17/2025 VR Adviser LLC2,457,348$21.97M1.5%-29.0%4.355% 2/17/2025 Vestal Point Capital LP4,180,000$37.37M2.2%+4.5%7.407% 2/17/2025 Two Sigma Investments LP19,428$174K0.0%-9.5%0.034% 2/17/2025 Sphera Funds Management LTD.139,800$1.25M0.2%+2.4%0.248% 2/17/2025 Rafferty Asset Management LLC37,571$336K0.0%-29.6%0.067% 2/17/2025 Redmile Group LLC346,278$3.10M0.2%+11.4%0.614% 2/17/2025 ProShare Advisors LLC15,706$140K0.0%N/A0.028% 2/17/2025 Patient Square Capital LP105,057$939K0.4%+166.5%0.186% 2/17/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC129,666$1.16M0.1%+4.4%0.230% 2/17/2025 Janus Henderson Group PLC17,700$159K0.0%N/A0.031% 2/17/2025 Fcpm Iii Services B.V.2,872,537$25.68M4.4%N/A5.090% Trump wipes out trillions overnight… (Ad)Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.Whether you take some of that wealth for yourself depends on if you watch this controversial exposé 2/17/2025 Deutsche Bank AG39,744$355K0.0%+54.3%0.070% 2/17/2025 DAFNA Capital Management LLC299,775$2.68M0.7%+17.9%0.531% 2/17/2025 Driehaus Capital Management LLC1,561,791$13.96M0.1%-3.5%2.768% 2/17/2025 Cubist Systematic Strategies LLC15,278$137K0.0%N/A0.027% 2/17/2025 BNP Paribas Financial Markets5,572$50K0.0%N/A0.010% 2/14/2025 Jane Street Group LLC26,093$233K0.0%-29.0%0.046% 2/14/2025 PDT Partners LLC10,507$94K0.0%-17.6%0.019% 2/14/2025 Northern Trust Corp458,234$4.10M0.0%+4.5%0.812% 2/14/2025 Virtus ETF Advisers LLC7,247$65K0.0%N/A0.013% 2/14/2025 Voya Investment Management LLC71,708$641K0.0%+367.4%0.127% 2/14/2025 Adage Capital Partners GP L.L.C.713,200$6.38M0.0%-7.1%1.264% 2/14/2025 Price T Rowe Associates Inc. MD17,762$159K0.0%+19.3%0.031% 2/14/2025 Hsbc Holdings PLC19,263$170K0.0%+9.0%0.034% 2/14/2025 Tower Research Capital LLC TRC5,299$47K0.0%+109.2%0.009% 2/14/2025 Dimensional Fund Advisors LP278,072$2.49M0.0%-0.8%0.493% 2/13/2025 Walleye Capital LLC145,402$1.30M0.0%-16.7%0.258% 2/13/2025 Barclays PLC97,820$875K0.0%+5.6%0.173% 2/13/2025 Raymond James Financial Inc.79,044$707K0.0%N/A0.140% 2/13/2025 Legal & General Group Plc31,418$281K0.0%+7.6%0.056% 2/13/2025 Invesco Ltd.17,992$161K0.0%-94.3%0.032% 2/13/2025 ADAR1 Capital Management LLC90,984$813K0.2%-2.5%0.161% 2/13/2025 Wells Fargo & Company MN23,569$211K0.0%+47.3%0.042% 2/12/2025 Geode Capital Management LLC950,397$8.50M0.0%-0.3%1.684% 2/12/2025 JPMorgan Chase & Co.54,664$489K0.0%+39.6%0.097% 2/11/2025 Vanguard Group Inc.2,677,353$23.94M0.0%+1.6%4.745% 2/11/2025 KLP Kapitalforvaltning AS4,600$41K0.0%N/A0.008% 2/11/2025 American Century Companies Inc.42,693$382K0.0%+9.9%0.076% 2/11/2025 Teacher Retirement System of Texas10,125$91K0.0%N/A0.018% 2/11/2025 Intech Investment Management LLC27,104$242K0.0%+31.2%0.048% 2/10/2025 Swiss National Bank66,600$595K0.0%+13.1%0.118% 2/7/2025 AlphaQuest LLC7,077$63K0.0%-21.4%0.013% 2/6/2025 Raymond James Financial Inc.79,044$707K0.0%N/A0.140% 2/6/2025 Charles Schwab Investment Management Inc.322,576$2.88M0.0%+2.6%0.572% 1/31/2025 New York State Common Retirement Fund10,720$96K0.0%+67.0%0.019% 1/30/2025 Rhumbline Advisers62,163$556K0.0%+2.3%0.110% 1/24/2025 China Universal Asset Management Co. Ltd.11,966$107K0.0%N/A0.021% 1/17/2025 SG Americas Securities LLC21,296$190K0.0%+51.3%0.038% 12/26/2024 JPMorgan Chase & Co.39,144$431K0.0%+101.7%0.069% 11/19/2024 Barclays PLC92,651$1.02M0.0%+70.5%0.164% 11/16/2024 Geode Capital Management LLC953,167$10.50M0.0%-6.0%1.689% 11/15/2024 Barclays PLC92,651$1.02M0.0%+70.5%0.164% 11/15/2024 Jane Street Group LLC36,736$404K0.0%-67.3%0.065% 11/15/2024 Wellington Management Group LLP147,499$1.62M0.0%+8.7%0.261% 11/15/2024 Sphera Funds Management LTD.136,582$1.50M0.2%-16.1%0.242% 11/15/2024 State Street Corp1,556,283$17.14M0.0%-24.1%2.758% 11/15/2024 RA Capital Management L.P.5,105,213$56.21M0.6%+1.2%9.049% 11/15/2024 Redmile Group LLC310,884$3.42M0.2%N/A0.551% 11/15/2024 Patient Square Capital LP39,422$434K0.2%N/A0.070% 11/14/2024 PDT Partners LLC12,749$140K0.0%N/A0.023% 11/14/2024 Vestal Point Capital LP4,000,000$44.04M3.3%+23.1%7.089% New Rule Hits in July — The Smart Money Already Moved (Ad)A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how11/14/2024 Sio Capital Management LLC504,887$5.56M2.2%-1.1%0.895% 11/14/2024 Walleye Capital LLC174,581$1.92M0.0%+69.3%0.309% 11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC55,696$613K0.0%N/A0.099% 11/13/2024 FMR LLC7,822,275$86.12M0.0%+29.2%13.864% 11/12/2024 Charles Schwab Investment Management Inc.314,265$3.46M0.0%+152.3%0.557% 11/9/2024 Intech Investment Management LLC20,665$228K0.0%N/A0.037% 11/7/2024 Quest Partners LLC9,004$99K0.0%+180.8%0.016% 10/3/2024 SG Americas Securities LLC14,078$155K0.0%N/A0.026% 9/16/2024 Cubist Systematic Strategies LLC281,410$2.56M0.0%N/A0.499% 8/27/2024 Logos Global Management LP500,000$4.55M0.4%-77.7%0.911% (Data available from 1/1/2016 forward) ATXS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ATXS shares? During the previous two years, 91 institutional investors and hedge funds held shares of Astria Therapeutics. The most heavily invested institutionals were FMR LLC ($86.12M), RA Capital Management L.P. ($56.21M), Vestal Point Capital LP ($37.37M), Vivo Capital LLC ($32.78M), Perceptive Advisors LLC ($30.75M), Fcpm Iii Services B.V. ($25.68M), and Vanguard Group Inc. ($23.94M).Learn more on ATXS's institutional investors. What percentage of Astria Therapeutics stock is owned by institutional investors? 98.98% of Astria Therapeutics stock is owned by institutional investors. Learn more on ATXS's institutional investor holdings. Which institutional investors have been buying Astria Therapeutics stock? Of the 73 institutional investors that purchased Astria Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($4.47M), Fcpm Iii Services B.V. ($2.87M), Perceptive Advisors LLC ($1.81M), FMR LLC ($1.77M), Armistice Capital LLC ($1.58M), Affinity Asset Advisors LLC ($1.07M), and Vestal Point Capital LP ($930K). How much institutional buying is happening at Astria Therapeutics? Institutional investors have bought a total of 21,538,602 shares in the last 24 months. This purchase volume represents approximately $220.04M in transactions. Which Astria Therapeutics major shareholders have been selling company stock? Of the 37 institutional investors that sold Astria Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Logos Global Management LP ($3.49M), VR Adviser LLC ($1.00M), StemPoint Capital LP ($626.68K), Affinity Asset Advisors LLC ($620.86K), State Street Corp ($495.44K), FMR LLC ($397.24K), and Millennium Management LLC ($360.35K). How much institutional selling is happening at Astria Therapeutics? Institutional investors have sold a total of 8,484,955 shares in the last 24 months. This volume of shares sold represents approximately $81.25M in transactions. Related Companies Aurinia Pharmaceuticals Institutional Ownership CureVac Institutional Ownership Mineralys Therapeutics Institutional Ownership Phibro Animal Health Institutional Ownership Arcus Biosciences Institutional Ownership Wave Life Sciences Institutional Ownership Syndax Pharmaceuticals Institutional Ownership Collegium Pharmaceutical Institutional Ownership Enliven Therapeutics Institutional Ownership Spyre Therapeutics Institutional Ownership This page (NASDAQ:ATXS) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astria Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astria Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ATXS Stock Free ATXS Stock Alerts